Israeli drug giant Teva Pharmaceutical Industries (TEVA) dropped its hostile bid for Mylan (MYL) and instead agreed to buy the global generic-drug business of Allergan (AGN) Monday. Teva’s and Allergan’s stocks both jumped, while Mylan’s plunged. Teva agreed to pay $33.75 billion in cash and $6.75 billion in stock for Allergan’s Actavis business, with Allergan retaining 50% of the future money from Teva’s generic lenalidomide, better known as
Major averages fell on mixed volume with the S&P 500 closing back below its 50dma and the NASDAQ Composite resting just above its 50dma. With the majors just a little more than -2% off their peaks, the markets could easily fall a few percent further if the choppy, sideways move that started in late 2014 continues. That said, new “actionable” stocks for the watch list have been plentiful, so continue to keep close watch on such names. Should the market find a relatively shallow floor in this extended sideways move, such stocks could present actionable buy points. Meanwhile, a good number of tech juggernauts have posted strong earnings reports for the quarter thus have gapped higher including GOOGL, PCLN, AMZN, EBAY, NFLX, and FB, though AAPL disappointed, and BIIB nosedived sending the biotech group, which had been one of the leading industry groups, lower. Futures are trading lower as the Chinese Shanghai Composite Index SHCOMP ended down 8.5%, its worst daily percentage fall since February 27, 2007. Fears are mounting that Chinese authorities will slow their market manipulations in propping up their markets. Analysts say the selling came as investors fear the government is curbing its buying of blue-chip stocks to test whether the market can support itself. As always, keep stops tight if you are holding any long positions, and take profits where you have them in context with the chart.
Bond ETFs could take a hit in a rising interest rate environment. BlackRock’s iShares launches two new interest rate hedged bond ETFs. A look at the iShares Interest Rate Hedged Emerging Markets Bond ETF and Interest Rate Hedged 10+ Year Credit Bond ETF to generate yields and hedge against higher rates. With Treasury yields rising in anticipation of the Federal Reserve potentially boosting interest rates later this year, issuers of exchange traded funds continue to meet advisors and investors for alternative fixed income exposure with interest rate hedged ETFs. BlackRock’s (NYSE: BLK ) iShares, the world’s largest ETF issuer, doubled the size of its interest rate hedged ETF lineup with the debuts of iShares Interest Rate Hedged Emerging Markets Bond ETF (NYSEArca: EMBH ) and the iShares Interest Rate Hedged 10+ Year Credit Bond ETF (NYSEArca: CLYH ) . Both are actively managed funds. Unlike traditional bond ETFs, the rate-hedged bond ETFs try to mitigate the negative effects of a rising rate environment through shorting Treasury futures to match the overall duration of their diversified bond holdings. Looking further out, these types of hedged-bond ETFs could provide suitable exposure to the fixed-income market in a rising interest environment, especially as the Federal Reserve plans on hiking rates sometime later this year. The iShares Interest Rate Hedged 10+ Year Credit Bond ETF “seeks to provide exposure to long-term U.S. investment grade bonds while mitigating interest rate risk by holding CLY (iShares 10+ Year Credit Bond ETF) and short positions in interest rate swaps,” according to iShares . Nearly two-thirds of CLYH’s bond holdings have maturities of 20 years or more with another 16% having maturities of 15 to 20 years. Forty-six of the new ETF’s holdings are rated BBB with another 33% rated A and 10.4% carrying AA ratings. The iShares Interest Rate Hedged Emerging Markets Bond ETF holds the iShares J.P. Morgan USD Emerging Markets Bond ETF (NYSEArca: EMB ) , the largest emerging markets bond ETFs, short positions in interest rate swaps. EMB is a popular yield play with a 30-day SEC yield of 5.04%, according to iShares data , but an effective duration of 7.24 years makes the ETF vulnerable to hawkish changes in Fed policy. EMBH helps alleviate that concern with an effective duration of just 0.22 years. “iShares interest rate hedged ETFs are the industry’s first actively managed interest rate hedged products that can potentially benefit from the established liquidity of existing bond funds. By holding shares of EMB and CLY in combination with interest rate swaps, EMBH and CLYH provide easy access to cost effective potential solutions for investors who are attempting to mitigate interest rate risk,” according to iShares. iShares introduced its first rate hedged ETFs in May 2014, the iShares Interest Rate Hedged Corporate Bond ETF (NYSEArca: LQDH ) and the iShares Interest Rate Hedged High Yield Bond ETF (NYSEArca: HYGH ) . Tom Lydon’s clients own shares of EMB. Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. (More…) I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it. I have no business relationship with any company whose stock is mentioned in this article.